Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate prophylaxis for post-cesarean shivering under spinal anesthesia
IRCT20120215009014N380Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postanesthetic shivering (PAS) comparing Magnesium sulfate with Placebo (2 arms). Primary endpoint: Shivering after spinal anesthesia. Started Feb 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20120215009014N380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N380.